Richard C. Hubbard

University of Nottingham Ningbo China — China

Medicine · Health Sciences

50h-index11.0kcitations101works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(31), Anesthesia and Pain Management(15), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(13), Protease and Inhibitor Mechanisms(11), Chronic Obstructive Pulmonary Disease (COPD) Research(10)

Publications100 total

Associations of hypoglycemic medications, cordycepin and vaccination with clinical outcomes in diabetic kidney disease patients with COVID-19
Renal Failure·2025Open Access
Testicular stage- and cell-specific expression of F-actin-binding proteins
Biology of Reproduction·2025
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity
Advances in Therapy·2025· 10 citedOpen Access
Re “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study”. Heerfordt et al [Letter]
International Journal of COPD·2025Open Access
Incidence and survival of Interstitial Lung Diseases in the UK in 2000-2022: real-world data from the OPCRD primary care database.
Epidemiology·2024
COPD exacerbations during and beyond the COVID-19 pandemic in the UK
Epidemiology·2023· 1 cited
The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets
Lung Cancer·2022Open Access
Who is assessed by a lung cancer nurse specialist in the English Cancer Patient Experience Survey?
Lung Cancer·2022· 2 cited
Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
Lung Cancer·2022Open Access
90-Day mortality following lung cancer surgery: contemporary outcomes from the English National Clinical Outcomes Audit
Lung Cancer·2022
S65 Genome-wide association study of survival times after diagnosis of idiopathic pulmonary fibrosis
2021Open Access
What is the Definition of Cure in Non-small Cell Lung Cancer?
Oncology and Therapy·2021· 15 citedOpen Access
Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic
2020· 7 citedOpen Access
The Green Anesthesiologist: How Each of Us Can Make a Positive Environmental Impact in Our World
ASA Monitor·2020
P2.16-21 Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England
Journal of Thoracic Oncology·2018· 1 citedOpen Access
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
European Respiratory Journal·2015· 905 citedOpen Access
P277 The Incidence Of Lung Cancer In People With Idiopathic Pulmonary Fibrosis And Connective Tissue Disease Associated Pulmonary Fibrosis In The Uk: A Population Based Study
Thorax·2014· 1 citedOpen Access
The European initiative for quality management in lung cancer care
European Respiratory Journal·2014· 50 citedOpen Access
199 Prognostic implications of blood tests performed routinely prior to surgical resection of non-small cell lung cancer
Lung Cancer·2014· 1 cited
135 Smoking and lung cancer in women
Lung Cancer·2012· 2 cited
page 1 of 5Next →

Frequent Co-authors

Ronald G. Crystal(20), G A Fells(9), Gilbert Geis(8), André M. Cantin(5), Noel G. McElvaney(5), Fumitaka Ogushi(5), Michael E. Kuss(5), Claus Vogelmeier(5), Peter C. Isakson(4), Kenneth M. Verburg(4), Shawn Yu(4), William W. Zhao(4), Sheela Talwalker(4), Michael C. Snabes(4), P. Birrer(4), Shobha Dhadda(4), Roland Buhl(4), Robert F. Hoyt(4), Stephanie Sellers(3), Mario Casolaro(3)